Baxter suffers loss in contaminated heparin case; Caraco delisted, merges with Sun;

> Baxter International has lost the first case in its ongoing legal dispute over the 2007-2008 heparin contamination. Item

> Quality-challenged Caraco Pharmaceutical Laboratories in Detroit has been removed from the New York Stock Exchange after voting to become a private company and merge with majority shareholders Sun Pharmaceutical Industries, Sun Pharma Global and Sun Laboratories Inc. Story

> There were 1,693 known incidents of counterfeit medicines last year, a rise of 7% over the 2009 figure. News

> GlaxoSmithKline plans to hire about 30 new employees at its Hamilton facility due to demand for its cervical cancer vaccine. Story

> West Pharmaceutical Services has begun construction on a compression molding plant in the Shanghai Qingpu Industrial Zone adjacent to the company's injection molding facility. West release

> The Healthcare Industry Group of professional service provider Alvarez & Marsal has allied with consultancy Rondaxe to provide manufacturing, supply chain and compliance services to drugmakers. Alvarez & Marsal release

> Cardinal Health has signed a three-year agreement with pharmacy benefit manager Prime Therapeutics to continue servicing its PrimeMail mail-service pharmacy. Cardinal Health/Prime announcement

> The six key challenges to safety risk management stem from data, communication, organization, talent, money and strategy. Interview (reg. req.)

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.